跳至主要内容
临床试验/ACTRN12611000586910
ACTRN12611000586910已完成未知

A prospective, doubled-masked, cross-over, randomised clinical trial to compare solution induced corneal staining rates between an investigational contact lens care solution, COMPLETE [Registered trade mark] Easy Rub [Registered trade mark] and renu [Registered trade mark] fresh [Trademark] solutions with commercially available contact lenses worn contralaterally over two and eight hours in experienced contact lens wearers

Abbott Medical Optics, Inc0 个研究点目标入组 55 人开始时间: 2011年6月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent;
  • -Be at least 18 years old, male or female;
  • -Willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
  • -Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses;
  • -Is correctable to at least 6/12 (20/40) or better in each eye with contact lenses;
  • -Be an experienced contact lens wearer;
  • -Be able to insert and remove contact lenses;
  • -Be willing to not wear contact lens wear for at least 24 hours before each stage of the clinical trial (after informed consent).

排除标准

  • -Any pre-existing ocular irritation, injury or condition (including infection or disease) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses;
  • -Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants;
  • -Use of or a need for concurrent category S3 and above ocular medication at enrolment and/or during the study;
  • -Use of or a need for any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant’s ocular health/physiology or contact lens performance either in an adverse or beneficial manner at enrolment and/or during the study;
  • N.B.: Systemic antihistamines are allowed on an ‘as needed basis’, provided they are not used prophylactically during the trial and at least 24 hours before study product is used;
  • -Eye surgery within 12 weeks immediately prior to enrolment for this trial;
  • -Previous corneal refractive surgery;
  • -Contraindications to contact lens wear;
  • -Known allergy or intolerance to ingredients in any of the study products;
  • -Currently enrolled in another clinical trial.
  • -Participation in a clinical trial within the previous 2 weeks for dispensing studies and 48 hours -between in-house studies;
  • -Pregnancy*;
  • -The Investigator may, at his/her discretion, exclude anyone who they believe may not be able to fulfil the study requirements, or if it is believed to be in the participant’s best interests.
  • *Formal testing of pregnancy is not required. A participant’s verbal report is sufficient.

研究者

相似试验